ArticleAmerican journal of cancer research2022

Identification of BIK as an unfavorable prognostic marker and novel therapeutic target in microsatellite stable colorectal cancer harboring KRAS mutations.

Peng Liu et al.PubMed ↗Full text ↗

No numbers read from the abstract.